NCT06637657View on ClinicalTrials.gov

Guided Optimisation of Long-term Disease rEduction in secoNdary Prevention of CVD

RecruitingOBSERVATIONAL
Enrollment

5,586

Participants

Timeline

Start Date

July 9, 2024

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions
Acute Coronary Syndrome
Interventions
OTHER

No intervention (observational study)

No intervention, only guideline implementation (observational study)

Trial Locations (1)

Unknown

RECRUITING

Amsterdam UMC, Amsterdam

Sponsors
All Listed Sponsors
collaborator

Dutch Network for Cardiovascular Research (WCN), Utrecht

UNKNOWN

collaborator

Novartis Pharmaceuticals

INDUSTRY

collaborator

Amarin Pharma Inc.

INDUSTRY

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER